点击注册小程序 查看完整报告 特别申明： 风险提示： 下游需求不及预期，技术迭代风险，产品价格大幅波动。 报告摘要 事件： 公司发布 2025 年半年度业绩预增公告，2025 年上半年度，公司预计实现归母净利润为 19.7-21.3 亿元，同比 增长 136%-155%；其中，Q2 单季度公司预计实现归母净利润 11.6-13.2 亿元，同比增长 122%-152%，环比增 长44%-63%。 点评： 2025 上半年制冷剂高景气延续，公司业绩同比高增 随着二代制冷剂（HCFCs）配额进一步削减，三代制冷剂（HFCs）自 2024 年起实施生产配额制，制冷剂供给 端持续收紧，叠加下游需求旺盛，制冷剂行业景气度持续提升，公司制冷剂相关产品盈利能力显著提升。2025 年 H1，公司氟化工原料均价 3629 元/吨，同比+10%，量 18.8 万吨，同比+12%；制冷剂均价 39372 元/吨，同 比+62%，销量 15.5 吨，同比-4%；含氟聚合物材料均价 38372 元/吨，同比-2.80%，销量 2.3 万吨，同比 +7%；含氟精细化学品均价 63064 元/吨，同比+21%，销量 2945 吨，同比+4% ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The report highlights that the refrigerant industry is experiencing a sustained boom, significantly boosting the company's performance. The company is expected to achieve a substantial increase in net profit for the first half of 2025, with estimates ranging from 1.97 to 2.13 billion yuan, representing a year-on-year growth of 136% to 155% [5][8] - The report anticipates that the company's revenue will continue to grow due to the high demand for high-end fluorinated new materials and the implementation of the third-generation refrigerant quota scheme, which is expected to enhance profitability further [8] Summary by Sections Company Overview - The latest closing price of the company's stock is 27.55 yuan, with a 12-month price range of 14.42 to 29.00 yuan. The total share capital is approximately 2,699.75 million shares, and the circulating market value is 74.378 billion yuan [2] Financial Performance - For the first half of 2025, the company expects to achieve a net profit attributable to shareholders of 1.97 to 2.13 billion yuan, with a year-on-year increase of 136% to 155%. The second quarter is projected to show a net profit of 1.16 to 1.32 billion yuan, reflecting a year-on-year growth of 122% to 152% and a quarter-on-quarter increase of 44% to 63% [5][6] - The refrigerant sales volume for the first half of 2025 is expected to be 154,600 tons, with an average price of 39,372.45 yuan per ton, leading to a revenue of 6.087 billion yuan, a year-on-year increase of 55.09% [6] Market Trends - The report indicates that the refrigerant market is entering a favorable cycle driven by quota systems and increasing downstream demand. The average prices for various refrigerants have shown significant increases, with R22, R32, R125, and R134a prices rising by -12%, 23%, 14%, and 22% respectively [6] - The non-refrigerant business also shows stable growth, with fluorochemical raw material sales volume increasing by 11.72% year-on-year, contributing to a revenue of 681 million yuan, a year-on-year increase of 23.16% [7] Future Projections - The company is projected to achieve revenues of 26.99 billion yuan, 30.05 billion yuan, and 34.20 billion yuan for the years 2025, 2026, and 2027 respectively, with growth rates of 10.3%, 11.3%, and 13.8% [8][11] - The net profit attributable to shareholders is expected to reach 4.407 billion yuan, 5.092 billion yuan, and 5.830 billion yuan for the same years, with growth rates of 124.9%, 15.5%, and 14.5% respectively [8][11]

浙江巨化股份有限公司 股票简称：巨化股份 股票代码：600160 公告编号：临 2025－35 2025 年上半年主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江巨化股份有限公司（以下简称"公司"）根据《上海证券交易所上市公司 自律监管指引第 3 号——行业信息披露（第十三号化工）》有关规定，将公司 2025 年上半年主要经营数据披露如下： | 主要产品 | 产量 | 同比 | 外销量 | 同比 | 营业收入 | 同比 | | --- | --- | --- | --- | --- | --- | --- | | | 吨 | % | 吨 | % | 万元 | % | | 氟化工原料 | 602145.62 | 11.44 | 187526.53 | 11.72 | 68059.20 | 23.16 | | 制冷剂 | 285057.83 | -5.12 | 154588.31 | -4.19 | 608652.07 | 55.09 | | 含氟聚合物材料 | 69098.79 | 8.49 | 22 ...

Investment Rating - The report maintains a "Strong Buy" investment rating for the company [3][7]. Core Views - The company reported a strong performance in Q1 2025, achieving revenue of 5.8 billion yuan, a year-on-year increase of 6.05%, and a net profit of 809 million yuan, up 160.64% year-on-year, indicating a robust recovery and growth trajectory [1][7]. - The company is positioned as a leader in the fluorochemical industry, particularly benefiting from the ongoing upcycle in refrigerants, with significant growth expected in the coming years [7]. - The report forecasts revenue growth for 2025-2027, estimating revenues of 29.36 billion yuan, 35.23 billion yuan, and 40.51 billion yuan respectively, alongside net profits of 3.30 billion yuan, 4.20 billion yuan, and 4.90 billion yuan [7][15]. Financial Data and Valuation - The company’s total revenue for 2023 is projected at 20.66 billion yuan, with a year-on-year decline of 4%, followed by a recovery with 18% growth in 2024 [15]. - The earnings per share (EPS) are expected to rise from 0.35 yuan in 2023 to 1.22 yuan in 2025, reflecting a strong growth outlook [15]. - The price-to-earnings (PE) ratio is projected to decrease from 72.6 in 2023 to 20.8 in 2025, indicating improving valuation metrics as earnings grow [15]. Market Position - The company has solidified its market position as a leading player in the fluorochemical sector, particularly in the production of fluorinated refrigerants and chlorinated raw materials, with a global leadership status [7]. - The first quarter of 2025 showed a significant increase in sales and production across key product lines, particularly in refrigerants, where average prices rose over 50% [7].

股票简称：巨化股份 股票代码：600160 公告编号：临 2025－11 浙江巨化股份有限公司 2025 年 1-3 月主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江巨化股份有限公司（以下简称"公司"）根据《上海证券交易所上市公司 自律监管指引第 3 号——行业信息披露（第十三号化工）》有关规定，将公司 2025 年 1-3 月主要经营数据披露如下： 【注】： 1、同比：指报告期与上年同期相比； 2、外销量低于产量，主要为部分产品作为内部下游产品原料所致； 3、基础化工产品中不含乙炔气、氢气、香精、冷冻油及其他非主要产品（下同）； 4、致冷剂（含全部品种）产量含混配致冷剂产量,产量大于销量主要为部分致冷剂用于公司混配致冷剂原料 所致。 二、主要产品和原材料的价格变动情况 第 1 页 共 3 页 主要产品 产量 同比 外销量 同比 营业收入 同比 吨 % 吨 % 万元 % 氟化工原料 292299.91 13.04 86881.55 11.07 32583.03 26.90 致冷剂 143563.6 ...